Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

PROFILEing idiopathic pulmonary fibrosis: rethinking biomarker discovery

Toby M. Maher
European Respiratory Review 2013 22: 148-152; DOI: 10.1183/09059180.00000913
Toby M. Maher
*Interstitial Lung Disease Unit, Royal Brompton Hospital, London, #Centre for Respiratory Research, University College London, London, and ¶National Heart and Lung Institute, Imperial College London, London, UK.
*Interstitial Lung Disease Unit, Royal Brompton Hospital, London, #Centre for Respiratory Research, University College London, London, and ¶National Heart and Lung Institute, Imperial College London, London, UK.
*Interstitial Lung Disease Unit, Royal Brompton Hospital, London, #Centre for Respiratory Research, University College London, London, and ¶National Heart and Lung Institute, Imperial College London, London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: t.maher@rbht.nhs.uk
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 22 no. 128 148-152
DOI 
https://doi.org/10.1183/09059180.00000913
PubMed 
23728868

Published By 
European Respiratory Society
Print ISSN 
0905-9180
Online ISSN 
1600-0617
History 
  • Received March 4, 2013
  • Accepted April 11, 2013
  • Published online May 31, 2013.

Copyright & Usage 
©ERS 2013

Author Information

  1. Toby M. Maher*,#¶⇑
  1. *Interstitial Lung Disease Unit, Royal Brompton Hospital, London, #Centre for Respiratory Research, University College London, London, and ¶National Heart and Lung Institute, Imperial College London, London, UK.
  1. T.M. Maher, Interstitial Lung Disease Unit, Royal Brompton Hospital, Sydney Street, London, SW3 6NP, UK. E-mail: t.maher{at}rbht.nhs.uk
View Full Text

Article usage

Article usage: May 2013 to February 2023

AbstractFullPdf
May 201327210
Jun 20131140201296
Jul 2013524111123
Aug 20134376178
Sep 20133606685
Oct 20135539485
Nov 20134504931
Dec 20131313132
Jan 20141498063
Feb 20141128069
Mar 20141858568
Apr 20141067660
May 20141156044
Jun 20141155841
Jul 20141007244
Aug 2014834621
Sep 20141415337
Oct 20141065034
Nov 2014926131
Dec 2014874024
Jan 2015715121
Feb 2015824438
Mar 2015973523
Apr 2015822727
May 2015982622
Jun 2015803849
Jul 2015865637
Aug 2015683929
Sep 2015345936
Oct 201587119
Nov 201565095
Dec 201554924
Jan 201645329
Feb 201675126
Mar 20161311435
Apr 2016156129
May 201676120
Jun 201675133
Jul 2016104633
Aug 201675840
Sep 2016226631
Oct 2016168024
Nov 20161910523
Dec 2016167230
Jan 2017116527
Feb 2017136518
Mar 2017116312
Apr 201794118
May 201755522
Jun 201774314
Jul 2017114514
Aug 2017214113
Sep 201756020
Oct 2017117613
Nov 2017109322
Dec 201776614
Jan 2018711519
Feb 20181110710
Mar 201888720
Apr 2018925614
May 201882407
Jun 2018732815
Jul 20182018416
Aug 2018413315
Sep 201831279
Oct 2018420718
Nov 2018625220
Dec 2018317914
Jan 201958316
Feb 201978413
Mar 201966711
Apr 20197429
May 2019113617
Jun 201983011
Jul 201963711
Aug 201933313
Sep 2019136119
Oct 201995216
Nov 201996815
Dec 201934026
Jan 202084413
Feb 2020183012
Mar 202054115
Apr 202023912
May 202074416
Jun 202024414
Jul 202014812
Aug 202033713
Sep 202014914
Oct 2020610123
Nov 202035719
Dec 202024925
Jan 202104423
Feb 202115619
Mar 202126526
Apr 202114615
May 202103921
Jun 202144219
Jul 202152824
Aug 202164420
Sep 202152521
Oct 202114331
Nov 202153743
Dec 202132511
Jan 202232314
Feb 202223218
Mar 202233917
Apr 202253118
May 202224316
Jun 202264033
Jul 202222917
Aug 202283312
Sep 202255326
Oct 202262611
Nov 202243514
Dec 202201618
Jan 202312610
Feb 20230218

Altmetrics

PreviousNext
Back to top
View this article with LENS
Vol 22 Issue 128 Table of Contents
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
PROFILEing idiopathic pulmonary fibrosis: rethinking biomarker discovery
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
PROFILEing idiopathic pulmonary fibrosis: rethinking biomarker discovery
Toby M. Maher
European Respiratory Review Jun 2013, 22 (128) 148-152; DOI: 10.1183/09059180.00000913

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
PROFILEing idiopathic pulmonary fibrosis: rethinking biomarker discovery
Toby M. Maher
European Respiratory Review Jun 2013, 22 (128) 148-152; DOI: 10.1183/09059180.00000913
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • DIAGNOSING IPF: THE LACK OF A GOLD STANDARD
    • PREDICTING DISEASE PROGRESSION
    • IDENTIFYING KEY DISEASE MECHANISMS
    • CLINICAL TRIAL DESIGN
    • DISEASE STRATIFICATION
    • A PATHWAY TO BETTER UNDERSTANDING
    • ADDRESSING THE PROBLEMS IN IPF: THE PROFILE STUDY
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Genetics
  • Interstitial and orphan lung disease
  • Mechanisms of lung disease
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Role of air pollutants in airway epithelial barrier dysfunction
  • E-cigarettes and nicotine abstinence
  • Lung imaging in cystic fibrosis
Show more Review

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERR

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising
  • Sponsorship

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN: 0905-9180
Online ISSN: 1600-0617

Copyright © 2023 by the European Respiratory Society